PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PIK3CA Gene Mutations in Solid Malignancies: Association with Clinicopathological Parameters and Prognosis
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 1, Pages 93
Publisher
MDPI AG
Online
2020-01-03
DOI
10.3390/cancers12010093
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The distinct clinicopathological and prognostic implications of PIK3CA mutations in breast cancer patients from Central China
- (2019) Haibo Wu et al. Cancer Management and Research
- Prognostic value of KRAS/TP53/PIK3CA in non‑small cell lung cancer
- (2019) Jiayi Zhao et al. Oncology Letters
- Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladder
- (2019) Sumit Isharwal et al. JOURNAL OF PATHOLOGY
- Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for PIK3CA-altered head and neck cancer
- (2019) Matthew L. Hedberg et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Co-mutation of TP53 and PIK3CA in residual disease after neoadjuvant chemotherapy is associated with poor survival in breast cancer
- (2019) Xinyi Chen et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Somatic alterations of TP53 , ERBB2 , PIK3CA and CCND1 are associated with chemosensitivity for breast cancers
- (2019) Libo Yang et al. CANCER SCIENCE
- Chemotherapy Modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast Cancer
- (2019) Dabo Zhou et al. Translational Oncology
- Associations between primary tumor RAS, BRAF and PIK3CA mutation status and metastatic site in patients with chemo-resistant metastatic colorectal cancer
- (2018) Troels Dreier Christensen et al. ACTA ONCOLOGICA
- Next-Generation Sequencing to Detect Deletion of RB1 and ERBB4 Genes in Chromophobe Renal Cell Carcinoma
- (2018) Qingqing Liu et al. AMERICAN JOURNAL OF PATHOLOGY
- Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: A French randomised double-blind phase III trial (PRODIGE 50-ASPIK)
- (2018) Pierre Michel et al. DIGESTIVE AND LIVER DISEASE
- Clinical Impact and Prognostic Role of KRAS/BRAF/PIK3CA Mutations in Stage I Colorectal Cancer
- (2018) Luca Reggiani Bonetti et al. DISEASE MARKERS
- Small cell cancers of the female genital tract: Molecular and clinical aspects
- (2018) Jay R. Patibandla et al. GYNECOLOGIC ONCOLOGY
- Somatic mutation profiling of vulvar cancer: Exploring therapeutic targets
- (2018) Sebastian Zięba et al. GYNECOLOGIC ONCOLOGY
- Next‑generation sequencing‑based detection of EGFR, KRAS, BRAF, NRAS, PIK3CA, Her‑2 and TP53 mutations in patients with non‑small cell lung cancer
- (2018) Changwen Jing et al. Molecular Medicine Reports
- Subjecting appropriate lung adenocarcinoma samples to next-generation sequencing-based molecular testing: challenges and possible solutions
- (2018) Weihua Li et al. Molecular Oncology
- Efficacy of PI3K/AKT/mTOR pathway inhibitors for the treatment of advanced solid cancers: A literature-based meta-analysis of 46 randomised control trials
- (2018) Xuan Li et al. PLoS One
- Prognostic role of PIK3CA and TP53 in human papillomavirus–negative oropharyngeal cancers
- (2018) Carlo Resteghini et al. TUMORI
- Differences in gene mutations according to gender among patients with colorectal cancer
- (2018) Yi-Jian Tsai et al. World Journal of Surgical Oncology
- Surface Enhanced Raman Spectroscopy (SERS) for the Multiplex Detection of Braf, Kras, and Pik3ca Mutations in Plasma of Colorectal Cancer Patients
- (2018) Xiaozhou Li et al. Theranostics
- Prevalence and Prognostic Role of PIK3CA/AKT1 Mutations in Chinese Breast Cancer Patients
- (2018) Ling Deng et al. Cancer Research and Treatment
- Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance
- (2018) Zhe-Yu Hu et al. EBioMedicine
- Prognostic role of PIK3CA and TP53 in human papillomavirus–negative oropharyngeal cancers
- (2018) Carlo Resteghini et al. TUMORI JOURNAL
- PIK3CA mutation is a favorable prognostic factor in esophageal cancer: molecular profile by next-generation sequencing using surgically resected formalin-fixed, paraffin-embedded tissue
- (2018) Tomoya Yokota et al. BMC CANCER
- RUNX2 Plays An Oncogenic Role in Esophageal Carcinoma by Activating the PI3K/AKT and ERK Signaling Pathways
- (2018) Huibin Lu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Driver mutations of young lung adenocarcinoma patients with malignant pleural effusion
- (2018) Shang-Gin Wu et al. GENES CHROMOSOMES & CANCER
- The genetic landscape of 87 ovarian germ cell tumors
- (2018) Els Van Nieuwenhuysen et al. GYNECOLOGIC ONCOLOGY
- Prognostic significance of PIK3CA mutation in stage IIB to IVA cervical cancers treated by concurrent chemoradiotherapy with weekly cisplatin
- (2018) Bouchra Lachkar et al. MEDICINE
- Lessons for cancer drug treatment from tackling a non-cancerous overgrowth syndrome
- (2018) Robert K. Semple et al. NATURE
- Cancer-Associated PIK3CA Mutations in Overgrowth Disorders
- (2018) Ralitsa R. Madsen et al. TRENDS IN MOLECULAR MEDICINE
- Targeted next-generation sequencing of 50 cancer-related genes in Japanese patients with oral squamous cell carcinoma
- (2018) Takafumi Nakagaki et al. TUMOR BIOLOGY
- Hotspot Mutations Detectable by Next-generation Sequencing in Exhaled Breath Condensates from Patients with Lung Cancer
- (2018) OMAR YOUSSEF et al. ANTICANCER RESEARCH
- Phosphatidylinositol 3-kinase pathway genomic alterations in 60,991 diverse solid tumors informs targeted therapy opportunities
- (2018) Sherri Z. Millis et al. CANCER
- Biomarkers of epithelial-mesenchymal transition in localized, surgically treated clear-cell renal cell carcinoma
- (2018) Anna Gasinska et al. FOLIA HISTOCHEMICA ET CYTOBIOLOGICA
- Human papillomavirus and the landscape of secondary genetic alterations in oral cancers
- (2018) Maura L. Gillison et al. GENOME RESEARCH
- A controlled trial of HNSCC patient-derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growth
- (2018) Kara M. Ruicci et al. INTERNATIONAL JOURNAL OF CANCER
- Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from Therapy
- (2018) Hyunseok Kang et al. ONCOLOGIST
- Pilot investigation of the mutation profile of PIK3CA/PTEN genes (PI3K pathway) in grade 3 endometrial cancer
- (2018) Francesca Malentacchi et al. ONCOLOGY REPORTS
- The genomic landscape of UM-SCC oral cavity squamous cell carcinoma cell lines
- (2018) Megan L. Ludwig et al. ORAL ONCOLOGY
- Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors
- (2018) Charles Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted next‑generation sequencing of cancer‑related genes in thyroid carcinoma: A single institution's experience
- (2018) Nobuyuki Bandoh et al. Oncology Letters
- Target sequencing of cancer-related genes in early esophageal squamous neoplasia resected by endoscopic resection in Japanese patients
- (2018) Shoji Kobayashi et al. Oncotarget
- PIK3CA mutations are frequent in esophageal squamous cell carcinoma associated with chagasic megaesophagus and are associated with a worse patient outcome
- (2018) Fernanda Franco Munari et al. Infectious Agents and Cancer
- Somatic mutation profiling of hobnail variant of papillary thyroid carcinoma
- (2017) Luca Morandi et al. ENDOCRINE-RELATED CANCER
- Analysis of KRAS , NRAS , PIK3CA , and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer
- (2017) Luca Reggiani Bonetti et al. HUMAN PATHOLOGY
- No significant association between PIK3CA mutation and survival of esophageal squamous cell carcinoma: A meta-analysis
- (2017) Xiao-qing Ge et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Single Point Mutations in Pediatric Differentiated Thyroid Cancer
- (2017) Ali S. Alzahrani et al. THYROID
- PIK3CA gene mutations in Northwest Chinese esophageal squamous cell carcinoma
- (2017) Shi-Yuan Liu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Genes with mutation significance were highly associated with the clinical pattern of patients with breast cancer
- (2017) Wan-Jun Ding et al. Oncotarget
- Molecular profiling of metastatic colorectal tumors using next-generation sequencing: a single-institution experience
- (2017) Jun Gong et al. Oncotarget
- Comparative molecular analyses of left-sided colon, right-sided colon, and rectal cancers
- (2017) Mohamed E. Salem et al. Oncotarget
- Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid Cancer
- (2017) Min-Young Lee et al. Cancer Research and Treatment
- Nephroblastomatosis or Wilms tumor in a fourth patient with a somaticPIK3CAmutation
- (2016) Karen W. Gripp et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells
- (2016) Wani Arjumand et al. Oncotarget
- Landscape of Phosphatidylinositol-3-Kinase Pathway Alterations Across 19 784 Diverse Solid Tumors
- (2016) Sherri Z. Millis et al. JAMA Oncology
- Impact of Reclassification on Thyroid Nodules with Architectural Atypia: From Non-Invasive Encapsulated Follicular Variant Papillary Thyroid Carcinomas to Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features
- (2016) Min Ji Jeon et al. PLoS One
- PIK3CA Somatic Mutation Status in Relation to Patient and Tumor Factors in Racial/Ethnic Minorities with Colorectal Cancer
- (2015) A. I. Phipps et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Genetic profiling of advanced radioactive iodine-resistant differentiated thyroid cancer and correlation with axitinib efficacy
- (2015) Rebecca B. Schechter et al. CANCER LETTERS
- Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer
- (2015) Luisa Foltran et al. Future Oncology
- Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing
- (2015) John W. Kunstman et al. HUMAN MOLECULAR GENETICS
- Mutations in PI3K/AKT pathway genes and amplifications of PIK3CA are associated with patterns of recurrence in gastric cancers
- (2015) Wen-Liang Fang et al. Oncotarget
- PIK3CA mutations predict recurrence in localized microsatellite stable colon cancer
- (2015) Gilles Manceau et al. Cancer Medicine
- Correlation between Activation of PI3K/AKT/mTOR Pathway and Prognosis of Breast Cancer in Chinese Women
- (2015) Ling Deng et al. PLoS One
- Clinical delineation and natural history of thePIK3CA-related overgrowth spectrum
- (2014) Kim M. Keppler-Noreuil et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART A
- Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis
- (2014) Peiwei Li et al. GUT
- Oncogenic mutations of the PIK3CA gene in head and neck squamous cell carcinomas
- (2014) Avaniyapuram Murugan et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Molecular Genetics of Clear-Cell Renal Cell Carcinoma
- (2014) James Brugarolas JOURNAL OF CLINICAL ONCOLOGY
- Activating BRAF and PIK3CA Mutations Cooperate to Promote Anaplastic Thyroid Carcinogenesis
- (2014) Roch-Philippe Charles et al. MOLECULAR CANCER RESEARCH
- Discovery and saturation analysis of cancer genes across 21 tumour types
- (2014) Michael S. Lawrence et al. NATURE
- Predictive and Prognostic Analysis of PIK3CA Mutation in Stage III Colon Cancer Intergroup Trial
- (2013) Shuji Ogino et al. JNCI-Journal of the National Cancer Institute
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- PIK3CA exon 20 mutations are associated with poor prognosis in breast cancer patients
- (2012) FR Mangone et al. Clinics
- Single Nucleotide Polymorphism rs17849071 G/T in the PIK3CA Gene Is Inversely Associated with Follicular Thyroid Cancer and PIK3CA Amplification
- (2012) Jeffrey C. Xing et al. PLoS One
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancer
- (2010) Todd W. Miller et al. JOURNAL OF CLINICAL INVESTIGATION
- Genetic Alterations in the Phosphatidylinositol-3 Kinase/Akt Pathway in Thyroid Cancer
- (2010) Mingzhao Xing THYROID
- Everolimus restores gefitinib sensitivity in resistant non-small cell lung cancer cell lines
- (2009) Silvia La Monica et al. BIOCHEMICAL PHARMACOLOGY
- PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies
- (2009) A. Sartore-Bianchi et al. CANCER RESEARCH
- Overexpression of PIK3CA is associated with lymph node metastasis in esophageal squamous cell carcinoma
- (2009) Akagi INTERNATIONAL JOURNAL OF ONCOLOGY
- PIK3CAMutation Is Associated With Poor Prognosis Among Patients With Curatively Resected Colon Cancer
- (2009) Shuji Ogino et al. JOURNAL OF CLINICAL ONCOLOGY
- FrequentPIK3CAgene amplification and its clinical significance in colorectal cancer
- (2009) Zeenath Jehan et al. JOURNAL OF PATHOLOGY
- An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer
- (2008) K. Stemke-Hale et al. CANCER RESEARCH
- PIK3CA Mutations and Copy Number Gains in Human Lung Cancers
- (2008) H. Yamamoto et al. CANCER RESEARCH
- PIK3CA Mutation/PTEN Expression Status Predicts Response of Colon Cancer Cells to the Epidermal Growth Factor Receptor Inhibitor Cetuximab
- (2008) M. Jhawer et al. CANCER RESEARCH
- Phosphatidylinositol 3-Kinase Hyperactivation Results in Lapatinib Resistance that Is Reversed by the mTOR/Phosphatidylinositol 3-Kinase Inhibitor NVP-BEZ235
- (2008) P. J.A. Eichhorn et al. CANCER RESEARCH
- Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers
- (2008) Ludovic Barault et al. INTERNATIONAL JOURNAL OF CANCER
- PIK3CA mutation occurs in nasopharyngeal carcinoma but does not significantly influence the disease-specific survival
- (2008) Chu-Chung Chou et al. MEDICAL ONCOLOGY
- PIK3CAcancer mutations display gender and tissue specificity patterns
- (2007) Silvia Benvenuti et al. HUMAN MUTATION
- Phosphatidylinositol 3-Kinase/Akt and Ras/Raf-Mitogen-Activated Protein Kinase Pathway Mutations in Anaplastic Thyroid Cancer
- (2007) Libero Santarpia et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinicopathological Analysis of Papillary Thyroid Cancer withPIK3CAAlterations in a Middle Eastern Population
- (2007) Jehad Abubaker et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started